Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 Black Phoenix Black Phoenix +336.94%
#4 aPriori aPriori +113.84%
#5 Bedrock Bedrock +73.65%
#6 Cysic Cysic +47.27%
#7 Prom Prom +39.78%
#8 Playnance Playnance +35.16%
#9 COTI COTI +30.31%
#10 Nillion Nillion +22.86%
Coin of the day
Wrapped One Wrapped One
Settings
Language
ENGLISH
Currency
USD
Theme
Primo Nutraceuticals Inc. Primo Nutraceuticals Inc.

Primo Nutraceuticals Inc.

BUGVF
Rank in Stocks #42824
Primo Nutraceuticals Inc. focuses on acquiring and developing commercial real... Primo Nutraceuticals Inc. focuses on acquiring and developing commercial real estate assets in Canada, specifically tailored for the cannabis cultivation sector. The company delivers comprehensive, ready-to-use facilities, integrated with all necessary infrastructure, for cannabis producers and processors. Furthermore, it holds a hemp project in Oregon and operates a greenhouse complex situated in Washington state. Established in 2014, the firm adopted its current name, Primo Nutraceuticals Inc., in October 2019, having previously been known as Bougainville Ventures Inc. Its corporate base is located in Vancouver, Canada.
Share Price
$0.000001
Last synced: 2025-01-17
Market Cap
$26.00
Change (1 day)
-99.00%
Change (1 year)
0.00%
Country
CA
Trade Primo Nutraceuticals Inc. (BUGVF)

Category

Healthcare
Revenue for Primo Nutraceuticals Inc. (BUGVF)
Revenue in Aug 2026 TTM: 0
According to Primo Nutraceuticals Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Primo Nutraceuticals Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN